CD14 as a potential prognostic factor and Bcl-2 as a therapeutic target in egyptian B-Cell chronic lymphocytic leukemia patients

CD14 as a potential prognostic factor and Bcl-2 as a therapeutic target in egyptian B-Cell chronic lymphocytic leukemia patients

INTRODUCTION: B-cell chronic lymphocytic leukemia (B-CLL) is a unique lymphoproliferative disorder that scarcely occurs under the age of 40. B-CLL represents a neoplastic disorder caused primarily by defective programmed cell death and accompanied by a myriad of cellular and humoral immune defects....

Full description

Bibliographic Details
Main Authors: Mohamed Mahmoud El-Khawanky, Mohamed Hanfy Morsy, Amina Mohamed Elnaggar, Ola Ali Hussin, Mohga Mahmoud Zaewer, Naglaa Ali Khalifa
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2019-01-01
Series:Journal of Applied Hematology
Subjects:
Apoptosis
B-cell chronic lymphocytic leukemia
Bcl-2
CD14
flow cytometry
immunophenotyping
Online Access:http://www.jahjournal.org/article.asp?issn=1658-5127;year=2019;volume=10;issue=1;spage=23;epage=28;aulast=El-Khawanky

Internet

http://www.jahjournal.org/article.asp?issn=1658-5127;year=2019;volume=10;issue=1;spage=23;epage=28;aulast=El-Khawanky

Similar Items